AA
VCYT icon

AlphaCentric Advisors’s Veracyte VCYT Stock Holding History

AlphaCentric Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Buy
6,948
+110
+2% +$4.61K 0.35% 103
2026
Q1 		$220K Buy
+6,838
New +$253K 0.22% 137

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AlphaCentric Advisors's VCYT Position: Q2 2026 in Review

AlphaCentric Advisors increased its Veracyte (VCYT) stake by 1.6% in Q2 2026, buying an estimated $4.61K and bringing the position to 6,948 shares worth $408K. The position accounts for 0.35% of the portfolio, ranked #103.

AlphaCentric Advisors first reported a position in VCYT in Q1 2026 and has held it in 2 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • AlphaCentric Advisors held 6,948 shares of Veracyte worth $408K as of Q2 2026.
  • AlphaCentric Advisors bought 110 Veracyte shares in Q2 2026, an estimated $4.61K.
  • Veracyte made up 0.35% of AlphaCentric Advisors's portfolio in Q2 2026, its #103 holding.
  • AlphaCentric Advisors first reported a position in Veracyte in Q1 2026 and has held it in 2 quarters since.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.